» Articles » PMID: 22690733

Biochemical Identification and Crystal Structure of Kynurenine Formamidase from Drosophila Melanogaster

Overview
Journal Biochem J
Specialty Biochemistry
Date 2012 Jun 14
PMID 22690733
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

KFase (kynurenine formamidase), also known as arylformamidase and formylkynurenine formamidase, efficiently catalyses the hydrolysis of NFK (N-formyl-L-kynurenine) to kynurenine. KFase is the second enzyme in the kynurenine pathway of tryptophan metabolism. A number of intermediates formed in the kynurenine pathway are biologically active and implicated in an assortment of medical conditions, including cancer, schizophrenia and neurodegenerative diseases. Consequently, enzymes involved in the kynurenine pathway have been considered potential regulatory targets. In the present study, we report, for the first time, the biochemical characterization and crystal structures of Drosophila melanogaster KFase conjugated with an inhibitor, PMSF. The protein architecture of KFase reveals that it belongs to the α/β hydrolase fold family. The PMSF-binding information of the solved conjugated crystal structure was used to obtain a KFase and NFK complex using molecular docking. The complex is useful for understanding the catalytic mechanism of KFase. The present study provides a molecular basis for future efforts in maintaining or regulating kynurenine metabolism through the molecular and biochemical regulation of KFase.

Citing Articles

Neuroactive Kynurenines as Pharmacological Targets: New Experimental Tools and Exciting Therapeutic Opportunities.

Pocivavsek A, Schwarcz R, Erhardt S Pharmacol Rev. 2024; 76(6):978-1008.

PMID: 39304346 PMC: 11549936. DOI: 10.1124/pharmrev.124.000239.


The Biology and Biochemistry of Kynurenic Acid, a Potential Nutraceutical with Multiple Biological Effects.

Alves L, Moore J, Kell D Int J Mol Sci. 2024; 25(16).

PMID: 39201768 PMC: 11354673. DOI: 10.3390/ijms25169082.


Stress and Kynurenine-Inflammation Pathway in Major Depressive Disorder.

Mingoti M, Bertollo A, de Oliveira T, Ignacio Z Adv Exp Med Biol. 2023; 1411:163-190.

PMID: 36949310 DOI: 10.1007/978-981-19-7376-5_8.


Tryptophan metabolism and disposition in cancer biology and immunotherapy.

Badawy A Biosci Rep. 2022; 42(11).

PMID: 36286592 PMC: 9653095. DOI: 10.1042/BSR20221682.


[Quantitative analysis of tryptophan and its metabolites in urine by ultra performance liquid chromatography-tandem mass spectrometry].

Li H, Cui L, Zhang G, Zhang M, Jiao L, Wu W Se Pu. 2021; 39(5):518-525.

PMID: 34227336 PMC: 9403997. DOI: 10.3724/SP.J.1123.2020.06022.


References
1.
Erhardt S, Olsson S, Engberg G . Pharmacological manipulation of kynurenic acid: potential in the treatment of psychiatric disorders. CNS Drugs. 2009; 23(2):91-101. DOI: 10.2165/00023210-200923020-00001. View

2.
Sanson B, Nachon F, Colletier J, Froment M, Toker L, Greenblatt H . Crystallographic snapshots of nonaged and aged conjugates of soman with acetylcholinesterase, and of a ternary complex of the aged conjugate with pralidoxime. J Med Chem. 2009; 52(23):7593-603. DOI: 10.1021/jm900433t. View

3.
Piser T . Linking the cytokine and neurocircuitry hypotheses of depression: a translational framework for discovery and development of novel anti-depressants. Brain Behav Immun. 2010; 24(4):515-24. DOI: 10.1016/j.bbi.2010.02.006. View

4.
Garcia G, Wirtz R, Barr J, Woolfitt A, Rosenberg R . Xanthurenic acid induces gametogenesis in Plasmodium, the malaria parasite. J Biol Chem. 1998; 273(20):12003-5. DOI: 10.1074/jbc.273.20.12003. View

5.
Emsley P, Cowtan K . Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr. 2004; 60(Pt 12 Pt 1):2126-32. DOI: 10.1107/S0907444904019158. View